SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

PhaseBio Pharmaceuticals Q3 EPS $(0.86) Down From $(0.40) YoY

PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.86) per share. This is a 115 percent decrease over losses of $(0.40) per share from the same period last year.

· 11/12/2020 16:08
PhaseBio Pharmaceuticals (NASDAQ:PHAS) reported quarterly losses of $(0.86) per share. This is a 115 percent decrease over losses of $(0.40) per share from the same period last year.